Grant: Discovery Grants Program - Individual
University of British Columbia
$23,000.00
Development of biocompatible coatings for magnetic nanoparticles
EF 2013-14
Résumé
Currently, the only approved application of magnetic particles is as contrast agents in magnetic resonance imaging (MRI). These particles, however, have great untapped potential. They, for example, could be used in many therapeutic applications including magnetically targeted anticancer therapy or magnetically controlled drug delivery to areas where it is difficult to deliver highly potent drugs (such as the eye) without having serious negative side effects on non-targeted organs. To enable therapeutic magnetic targeting, we plan to prepare magnetite nanoparticles with purposefully designed coatings that give them high stability, good biocompatibility, and a ""hook"" to attach to many different molecules such as antibodies, peptides, fluorescent dyes and drugs. These magnetic nanoparticles will be evaluated on their own and additionally encapsulated in larger magnetic microspheres. The uniform size of these microspheres makes them react in a predictable way to an external magnetic field while they flow through a patient's blood stream. Such predictability has been missing from currently available non-toxic microspheres as they are mixtures of many different sizes. To confirm the success of our strategy, magnetic nanoparticles and microspheres will be evaluated in cell culture and microscopy experiments, followed by an in vivo eye model of magnetic targeting.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
312284-2010
Name nom
Hafeli, Urs
Department département
Pharmaceutical Sciences, Faculty of
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2010
Award amount
23000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
2004
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Polymers and coatings
Research subject fr
Polymères et revêtements
Partie
4
Nb partie
5
Application title
Development of biocompatible coatings for magnetic nanoparticles
Keyword
NSERC
Application summary
Currently, the only approved application of magnetic particles is as contrast agents in magnetic resonance imaging (MRI). These particles, however, have great untapped potential. They, for example, could be used in many therapeutic applications including magnetically targeted anticancer therapy or magnetically controlled drug delivery to areas where it is difficult to deliver highly potent drugs (such as the eye) without having serious negative side effects on non-targeted organs. To enable therapeutic magnetic targeting, we plan to prepare magnetite nanoparticles with purposefully designed coatings that give them high stability, good biocompatibility, and a ""hook"" to attach to many different molecules such as antibodies, peptides, fluorescent dyes and drugs. These magnetic nanoparticles will be evaluated on their own and additionally encapsulated in larger magnetic microspheres. The uniform size of these microspheres makes them react in a predictable way to an external magnetic field while they flow through a patient's blood stream. Such predictability has been missing from currently available non-toxic microspheres as they are mixtures of many different sizes. To confirm the success of our strategy, magnetic nanoparticles and microspheres will be evaluated in cell culture and microscopy experiments, followed by an in vivo eye model of magnetic targeting.